Luxturna treatment in the UK

Luxturna (voretigene neparvovec) is an approved retinal gene therapy in the UK for Leber congenital amaurosis (LCA) and retinitis pigmentosa (RP) caused by mutations in the RPE65 gene. 

Affected UK patients are able to receive Luxturna treatment under the NHS through these four specialist centres: 

Updated on November 29, 2020
Was this article helpful?